Susan Blum
Director of Finance/CFO at MELINTA THERAPEUTICS, INC.
Profile
Susan Blum is currently an Independent Director at BiomX, Inc. and the Chief Financial Officer at Melinta Therapeutics, Inc. She completed her undergraduate degree at Santa Clara University.
Susan Blum active positions
| Companies | Position | Start |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Director of Finance/CFO | 2021-06-30 |
| BIOMX INC. | Director/Board Member | 2024-04-10 |
Training of Susan Blum
| Santa Clara University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOMX INC. | Health Technology |
| Private companies | 1 |
|---|---|
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
- Stock Market
- Insiders
- Susan Blum
